profit from every $100 of sales.
$0$100
Mettler-Toledo International
$1,738.91+0.46% today
+23.1% in 1 year
1-year low $1,025.531-year high $1,762.28
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $39.79 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Mettler-Toledo International sold, what it kept, and what it did with the cash.
Sales went from $3.92 billion in 2022 to $4.03 billion in 2025, with $869 million of profit last year.
SalesProfit
Mettler-Toledo International handed back 94% of the cash it generated last year.
Buybacks $800M
Free cash flow 2025$849M
Bought back its own shares$800M
Paid as dividends–
Cash vs. debt$67M vs. $2.2B
Mettler-Toledo International vs. similar companies
Mettler-Toledo International grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Mettler-Toledo International | 39.8× · Expensive | ||
 Thermo Fisher Scientific | 38.7× · Expensive | ||
 Danaher | 45.4× · Expensive | ||
 Waters | 140.8× · Very expensive | ||
 WuXi AppTec | 25.8× · Fair price |
Compare Mettler-Toledo International with Agilent Technologies
AI analysis
An AI analyst reads Mettler-Toledo International's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 3,085 | 3,718 | 3,920 | 3,788 | 3,872 | 4,026 | |
| 1,801 | 2,172 | 2,308 | 2,241 | 2,326 | 2,391 | |
| – | – | 1,126 | 1,080 | 1,127 | 1,118 | |
| – | – | 1,239 | 1,172 | 1,235 | 1,243 | |
| 603 | 769 | 873 | 789 | 863 | 869 | |
| 24.91 | 32.78 | 38.41 | 35.90 | 40.48 | 42.05 | |
| 58.4% | 58.4% | 58.9% | 59.2% | 60.1% | 59.4% | |
| – | – | 28.7% | 28.5% | 29.1% | 27.8% | |
| 19.5% | 20.7% | 22.3% | 20.8% | 22.3% | 21.6% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 2,815 | 3,327 | 3,492 | 3,356 | 3,240 | 3,713 |
| Cash | 94 | 99 | 96 | 70 | 59 | 67 |
| Total debt | 1,334 | 1,682 | 2,015 | 2,081 | 2,014 | 2,152 |
| Total liabilities | 2,532 | 3,155 | 3,468 | 3,505 | 3,367 | 3,736 |
| 283 | 171 | 25 | -150 | -127 | -24 | |
| 24 | 23 | 23 | 22 | 21 | 21 | |
| 38.5% | 42.3% | 43.6% | 43.0% | 46.5% | 41.5% | |
| 213.2% | 448.6% | 3,519.1% | -526.1% | -680.2% | -3,677.4% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 725 | 909 | 859 | 966 | 968 | 956 | |
| 92 | 108 | 121 | 105 | 104 | 107 | |
| 632 | 801 | 738 | 861 | 864 | 849 | |
| Dividends paid | – | – | – | – | – | – |
| 775 | 1,000 | 1,100 | 900 | 850 | 800 | |
| 19 | 20 | 20 | 18 | 20 | 23 |
Valuation
- 39.8×
- 37.4×
- 3.60
- -1,423.4×
- 8.6×
- 40.8×
- 29.5×
- 2.5%
- 2.5%
- 0.0%
Profitability
- 59.4%
- 27.8%
- 21.6%
- 30.3%
- 42.5%
- 44.8%
- -610.3%
- 23.9%
- 44.7%
- 5.0%
Growth
- +5.5%
- +11.0%
- −1.8%
- –
- −3.1%
Financial health
- 1.7×
- -91.05
- 60.7%
- 16.3×
- 1.14
- 0.84
- 1.11
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 2%of 964
Top 13%of 898
Bottom 31%of 651
Bottom 31%of 911
Top 42%of 991
What analysts expect
- Average price target
- $1,490.83
- Range
- $1,445.00 – $1,600.00
- 3 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 7, 2026 | 8.91 | 8.70 | +2.4% |
| Feb 5, 2026 | 13.36 | 12.80 | +4.4% |
| Nov 6, 2025 | 11.15 | 10.66 | +4.6% |
| Jul 31, 2025 | 10.09 | 9.60 | +5.1% |
| May 1, 2025 | 8.19 | 7.88 | +3.9% |
| Feb 6, 2025 | 12.41 | 11.72 | +5.9% |
| Nov 8, 2024 | 10.21 | 10.01 | +2.0% |
| Aug 1, 2024 | 9.65 | 9.03 | +6.9% |
News
Guidance Up, Trend Intact: Mettler-Toledo Is Today's Double-Confirmation StockYahoo Finance · Nov 4, 20263 Reasons MTD is risky and 1 stock to buy insteadYahoo Finance · Oct 24, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
4/7Passes 4 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
68Pass
Benjamin Graham
39No pass
Philip Fisher
76Pass
Peter Lynch
33No pass
Joel Greenblatt
43No pass
Charlie Munger
84Pass
Terry Smith
80Pass
Questions about Mettler-Toledo International
Is Mettler-Toledo International a good stock to buy?
A strong, very profitable business, but the price is high. 4 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Mettler-Toledo International AI analysis
What does Mettler-Toledo International do?
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. It is in Diagnostics & Research, based in Greifensee, Switzerland, with 16,600 employees.
Does Mettler-Toledo International pay a dividend?
No. Mettler-Toledo International does not pay a dividend at the moment; in 2025 it returned $800 million to shareholders by buying back its own shares.
Is Mettler-Toledo International stock halal?
Yes. Mettler-Toledo International passes our halal screen: its business is permitted and its debt is 6% of its market value, under the 30% limit. How we check
How has Mettler-Toledo International stock done over the past year?
Up 23.1% over the past twelve months, to $1,738.91. It traded between $1,025.53 and $1,762.28, close to its high.
Who are Mettler-Toledo International's competitors?
The largest listed companies in the same industry are Thermo Fisher Scientific, Danaher, Waters and WuXi AppTec. The peers table on this page compares their profit, growth and price with Mettler-Toledo International's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.